Effect of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-guided Management of Suspected Recurrent Papillary Thyroid Carcinoma: Long-term Follow-up with Tumour Marker Responses

2012 ◽  
Vol 24 (10) ◽  
pp. e168-e172 ◽  
Author(s):  
K. Dennis ◽  
J.H. Hay ◽  
D.C. Wilson
Keyword(s):  
Computed Tomography ◽  
Tumour Marker ◽  
Emission Tomography ◽  
Fluorodeoxyglucose Positron Emission Tomography ◽  
Papillary Thyroid ◽  
Positron Emission ◽  
Long Term Follow Up ◽  
Fluorodeoxyglucose Positron Emission

Limits of 18F-Fluorodeoxyglucose Positron Emission Tomography in Recurrence Diagnosis of Borderline Ovarian Tumor

2010 ◽  
Vol 20 (5) ◽  
pp. 694-697
Author(s):  
Margherita Giorgini ◽  
Claudia Marchetti ◽  
Violante Di Donato ◽  
Jacopo Tesei ◽  
Natalina Manci ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Primary Treatment ◽  
Emission Tomography ◽  
Borderline Ovarian Tumor ◽  
Fluorodeoxyglucose Positron Emission Tomography ◽  
Positron Emission ◽  
Long Term Follow Up ◽  
Fluorodeoxyglucose Positron Emission

Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOT with invasive peritoneal implants, which have a worse prognosis. We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT.

Sign in / Sign up

Export Citation Format

Share Document